#Canada #Probiotics #Chino #Bacillus clausii #VHP

Bacillus clausii 088AE: A Milestone for Dog Probiotics

In an exciting development for pet health, Specialty Enzymes & Probiotics has achieved a groundbreaking milestone with its probiotic strain, Bacillus clausii 088AE. This innovative company has announced that this specific strain is the first of its kind to receive a place on Health Canada's Veterinary Health Product (VHP) list tailored for canine health.

Achieving VHP status is no simple feat; the vetting process demands stringent evaluations that check for accurate strain identification, safety documentation, manufacturing consistency, and substantiation of health claims. Meeting each of these rigorous criteria, Bacillus clausii 088AE sets a new standard for spore-forming probiotics within the realm of companion animal care.

For brands that create pet supplements, this distinction represents a significant differentiator in a marketplace that is saturated with similar products. Ingredients that are backed by VHP listing provide essential regulatory credibility, which is invaluable for retailers, veterinarians, and pet owners who prefer evidence-based formulations for their furry friends.

Reshma Rathi, Vice President of Specialty Enzymes & Probiotics, notes, "With FDA GRAS status and approved Health Canada claims, Bacillus clausii 088AE has already laid a solid regulatory and scientific foundation in human health. The recognition by VHP translates that credibility to the realm of pet products, allowing formulators to offer a truly unique, scientifically supported probiotic option."

This remarkable strain is not just a standalone version; it forms a crucial part of the ProbioSEB CSC3 Pet™ product, which is a three-strain blend designed for companion animals focusing on gut and immune health. The development of this product underscores Specialty Enzymes & Probiotics' commitment to enhancing the well-being of pets through scientifically validated solutions.

As pet owners grow increasingly conscious about the health of their companions, this announcement is timely. Customers are seeking health supplements that are not only effective but also backed by scientific data. The VHP listing serves to enhance consumer confidence in these probiotic options, creating a ripple effect in retail environments where well-informed buying decisions are becoming the norm.

Specialty Enzymes & Probiotics boasts a rich history of more than 45 years in fermentation expertise, further adding to the legitimacy of their products. Their offerings have undergone extensive testing and have been supported by clinical trials and research published in leading peer-reviewed journals. These products are designed to foster joint, muscle, cardiovascular, and immune health, as well as promote digestive health and support sports nutrition among pets.

All products are manufactured in state-of-the-art facilities certified by NSF GMP, showcasing the firm’s dedication to quality and safety. These manufacturing sites adhere to a variety of elite certifications, including The Non-GMO Project and OK Kosher, with thorough testing conducted by third-party laboratories compliant with ISO-17025 standards.

In conclusion, the entry of Bacillus clausii 088AE onto Health Canada's VHP list is not just a noteworthy accomplishment for Specialty Enzymes & Probiotics, but it is also a significant advancement for the pet health industry. It gives pet product formulators access to a distinctive and evidence-based probiotic, enhancing the range of health options available to our beloved companions.

For more information on integrating Bacillus clausii 088AE or the ProbioSEB CSC3 Pet™ into your pet product line, you can reach out at specialtyenzymes.com or call (909) 613-1660.